Disease | lung cancer |
Symptom | C0013404|breathlessness |
Sentences | 6 |
PubMedID- 22469670 | There is good evidence to support the role of multicomponent, nonpharmacological interventions in reducing breathlessness for patients with copd and lung cancer, although further studies are required to understand the particular clinical contexts in which such interventions are appropriate. |
PubMedID- 23488372 | Managing breathlessness in patients with lung cancer. |
PubMedID- 26111954 | The aim of this study was to assess the feasibility and acceptability of a clinical trial of a new non-pharmacological intervention for the management of the respiratory distress symptom cluster, consisting of breathlessness-cough-fatigue, in patients with lung cancer. |
PubMedID- 22270088 | Background: a respiratory distress symptom cluster has recently been identified in lung cancer associated with breathlessness, cough and fatigue, and the study reported here is part of a wider body of work being undertaken to develop a novel non-pharmacological intervention (npi) for the management of this symptom cluster. |
PubMedID- 25417042 | Objectives: breathlessness in patients with lung cancer is a common and distressing symptom affecting 50-70 % of patients, rising to some 90 % for those with advanced lung cancer. |
PubMedID- 23094954 | Design: the study consisted of structured face-to-face interviews with patients suffering from breathlessness due to lung cancer (lc), chronic obstructive pulmonary disease (copd), chronic heart failure (chf), and motor neurone disease (mnd). |
Page: 1